Streetbeat News

Products Services

NKTX

Nkarta has initiated an investigator-sponsored trial of NKX019, a CD19-directed chimeric antigen receptor NK-cell therapy for systemic lupus erythematosus. Additionally, in June 2024, Nkarta initiated the NTRUST-1 Phase 1 trial of NKX019 for lupus nephritis.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:07 am

TEL

TE Connectivity reported Q3 orders of $4.1 billion, marking a 4% year-over-year increase and a 3% sequential rise, driven by momentum in artificial intelligence programs.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:06 am

TSLA

General Motors (GM) has halted the development of its Origin autonomous vehicle, citing regulatory concerns, but Tesla CEO Elon Musk claims the real reason is GM's technological shortcomings. GM will now focus on the next-generation Chevrolet Bolt for its Cruise unit's autonomous operations. Cruise co-founder Kyle Vogt expressed disappointment, accusing GM of abandoning innovative projects prematurely.

Portfolio Pulse from Anan Ashraf

July 24, 2024 | 10:03 am

AAPL

META

Mark Zuckerberg criticized Apple's rejection of Meta's AI partnership proposal, calling Apple's tactics 'soul-crushing.' Meta aims to release the largest open-source AI model to avoid Apple's control. Apple has partnered with OpenAI and is in talks with other AI firms.

Portfolio Pulse from Ananya Gairola

July 24, 2024 | 9:44 am

AAPL

NVDA

TSM

Japan's Prime Minister Fumio Kishida announced a new bill to boost domestic investment in AI and semiconductor production. The bill aims to support research, development, and large-scale production of next-generation chips, particularly through Rapidus Corp. This move is part of Japan's strategy to triple its domestic semiconductor sales by 2030 and diversify its chip supply chain. The announcement comes amid global semiconductor rivalry, particularly between the U.S. and China. Major tech companies like Nvidia and Apple, which rely on TSMC for chips, could be impacted by these developments.

Portfolio Pulse from Benzinga Neuro

July 24, 2024 | 9:40 am

GOOG

GOOGL

META

Alphabet, Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) reported strong Q2 earnings and revenue, but concerns over higher AI-related CapEx and mixed key metrics, including YouTube ad revenue, led to a stock decline. Fund manager Gene Munster emphasized the importance of AI investments to avoid future risks.

Portfolio Pulse from Shanthi Rexaline

July 24, 2024 | 9:22 am

META

TSLA

Elon Musk, CEO of Tesla and founder of xAI, has publicly supported Meta CEO Mark Zuckerberg's stance on open-source AI models. This endorsement is significant given their rivalry, especially after Meta launched Threads to compete with Twitter, which Musk owns. Musk's support aligns with his criticism of OpenAI's shift from a non-profit, open-source model to a profit-oriented, closed-source structure.

Portfolio Pulse from Ananya Gairola

July 24, 2024 | 9:16 am

AMZN

Amazon.com Inc. (NASDAQ:AMZN) has launched online pharmacy and drug delivery services in Japan, expanding its global healthcare presence. This initiative involves collaboration with approximately 2,500 drug stores and aims to provide medications without the need for physical pharmacy visits.

Portfolio Pulse from Benzinga Neuro

July 24, 2024 | 8:34 am

GILD

Gilead Sciences announced positive Phase 3 trial results for Lenacapavir, showing 100% efficacy in preventing HIV infections in cisgender women.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:33 am

AAPL

GOOG

META

Mark Zuckerberg, CEO of Meta Platforms Inc. (NASDAQ:META), is seeking public opinion on AI-generated outfits using Meta's latest AI model, Llama 3.1. This initiative aligns with Meta's broader AI ambitions, aiming to compete with tech giants like Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) and Apple Inc. (NASDAQ:AAPL). Meta has also acquired a 5% stake in EssilorLuxottica, the parent company of streetwear brand Supreme.

Portfolio Pulse from Benzinga Neuro

July 24, 2024 | 8:19 am